Acetyl Dipeptide-3 Aminohexanoate
Ac-Arg-(6-aminohexanoyl)-Ala, a cosmetic peptide with a non-protein spacer. PubMed holds no study of it.
Acetyl dipeptide-3 aminohexanoate is a synthetic molecule, acetyl-arginine joined through 6-aminohexanoic acid to alanine (PubChem's record, under its INCI name). It is sold as a skin-care ingredient, but a title-and-abstract search of PubMed for its INCI name finds no study of it. It is not a drug.
No dosing data yet Details ↓
Recommended Dosing
No dosing data yet
This page has no dosing data yet.
Mechanism of action
Not established: no published study describes its action.
Primary uses
- Cosmetic skin-care formulations
Typical dosing
No published study states an amount of this ingredient used on skin, and a supplier's use level is not a source on this site, so none is given.
Regulatory status
Not a drug: PubChem lists it under its INCI name as a cosmetic ingredient (CID 169450577). Drugs@FDA and the EMA medicines list hold no record for it (searched October 28, 2026).
Status as of this entry's last review, October 28, 2026. Approvals, compounding rules and sport rules change; the regulatory tracker is checked more often.
What we checked
Acetyl Dipeptide-3 Aminohexanoate is a cosmetic peptide ingredient with little or no published literature; this section records what can be checked.
Identity, computed
| Structure | N-acetyl-Arg-(6-aminohexanoyl)-Ala, free acid (read from PubChem's IUPAC name, CID 169450577) |
| Formula | C17H32N6O5 (PubChem) |
| Molecular weight | 400.5 g/mol (PubChem) |
The chain contains 6-aminohexanoic acid, which the calculator used elsewhere on this site does not handle, so the formula and weight are PubChem's, not computed here.
Regulatory status, read October 28, 2026
Drugs@FDA: 0 records for “acetyl dipeptide-3 aminohexanoate”. EMA medicines list: 0 records for “acetyl dipeptide-3 aminohexanoate”. Run for semaglutide, the same queries return 6 and 5 records (and the registry search 80 trials), so a zero here is an absence, not a broken search. Not named on the WADA 2026 and 2027 Prohibited Lists. As a substance with no current approval for human therapeutic use, it falls under section S0 (non-approved substances), which is prohibited at all times; the lists were read on October 28, 2026.
What we looked for and did not find
No published study of any kind, no registry record and no drug approval.
| Source | Query | Results, October 28, 2026 | What it was |
|---|---|---|---|
| PubMed | ("dipeptide-3"[tiab] AND acetyl[tiab] AND aminohexanoate[tiab]) | 0 | name matched word by word |
| ClinicalTrials.gov | acetyl dipeptide-3 aminohexanoate | 0 | |
| Drugs@FDA (openFDA) | acetyl dipeptide-3 aminohexanoate | 0 | |
| EMA medicines list | acetyl dipeptide-3 aminohexanoate | 0 |
References
- [other] PubChem CID 169450577, Acetyl Dipeptide-3 Aminohexanoate: formula C17H32N6O5, molecular weight 400.5. Read October 28, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/169450577
Related peptides
Guides & tools
Explore with tools
This entry is for educational purposes only and does not constitute medical advice. Dosing information reflects published regulatory or research data and is not a recommendation. Many compounds described here are not approved for human use in the United States. Consult a licensed medical professional before considering any peptide therapy.